EUVIMEDEUVIMED entdecken
Open Access

Evaluation of muc1, muc2, muc5ac, and muc6 expression differences in lung adenocarcinoma subtypes by using a final immunoreactivity score (firs)

Melek Buyuk, Yasemin Ozluk, Dogu Vuralli Bakkaloglu, Berker Ozkan, Pinar Firat, Dilek Yilmazbayhan

Turkish Journal of Pathology · 2022

DOI: 10.5146/tjpath.2022.01593 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Turkish Journal of Pathology, 2022. Verfasst von Melek Buyuk und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pathology, Istanbul Faculty of Medicine, Istanbul University, ISTANBUL, TURKEY. Hauptthemen laut MEDLINE: Adenocarcinoma of Lung, Adenocarcinoma, Mucinous, Lung Neoplasms. Die Arbeit wurde bisher 6-mal zitiert (Crossref). Der Volltext ist frei in PubMed Central verfügbar.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Adenocarcinoma of LungAdenocarcinoma, MucinousLung NeoplasmsHumansBiomarkers, TumorLymphatic MetastasisMucin 5ACMucin-1Mucin-2Mucin-6Retrospective Studies

Substanzen

Biomarkers, TumorMUC1 protein, humanMUC2 protein, humanMUC5AC protein, humanMUC6 protein, humanMucin 5ACMucin-1Mucin-2Mucin-6

Autor:innen und Institutionen

  • Department of Pathology, Istanbul Faculty of Medicine, Istanbul University, ISTANBUL, TURKEY.

Zitieren

APA

Buyuk, M., Ozluk, Y., Bakkaloglu, D. V., Ozkan, B., Firat, P., & Yilmazbayhan, D. (2022). Evaluation of muc1, muc2, muc5ac, and muc6 expression differences in lung adenocarcinoma subtypes by using a final immunoreactivity score (firs). Turkish Journal of Pathology. https://doi.org/10.5146/tjpath.2022.01593

Vancouver

Buyuk M, Ozluk Y, Bakkaloglu DV, Ozkan B, Firat P, Yilmazbayhan D. Evaluation of muc1, muc2, muc5ac, and muc6 expression differences in lung adenocarcinoma subtypes by using a final immunoreactivity score (firs). Turkish Journal of Pathology. 2022. doi:10.5146/tjpath.2022.01593

BibTeX
@article{Buyuk2022,
  author = {Buyuk, Melek and Ozluk, Yasemin and Bakkaloglu, Dogu Vuralli and Ozkan, Berker and Firat, Pinar and Yilmazbayhan, Dilek},
  title = {Evaluation of muc1, muc2, muc5ac, and muc6 expression differences in lung adenocarcinoma subtypes by using a final immunoreactivity score (firs)},
  journal = {Turkish Journal of Pathology},
  year = {2022},
  doi = {10.5146/tjpath.2022.01593}
}
Kostenlos starten →